Veeva Systems (VEEV) 10-Q9 Dec 202021 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Oct. 31, 2020	Nov. 30, 2020
Document And Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2020
Document Transition Report	false
Entity File Number	001-36121
Entity Registrant Name	Veeva Systems Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-8235463
Entity Address, Address Line One	4280 Hacienda Drive
Entity Address, City or Town	Pleasanton
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94588
City Area Code	925
Local Phone Number	452-6500
Title of 12(b) Security	Class A Common Stock,par value $0.00001 per share
Trading Symbol	VEEV
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001393052
Current Fiscal Year End Date	--01-31
Class A common stock
Document And Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		136,371,936
Class B common stock
Document And Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		15,093,651

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Current assets:
Cash and cash equivalents	$ 634,265	$ 476,733
Short-term investments	956,167	610,015
Accounts receivable, net of allowance for doubtful accounts of $516 and $617, respectively	183,435	389,690
Unbilled accounts receivable	53,235	32,817
Prepaid expenses and other current assets	25,895	21,869
Total current assets	1,852,997	1,531,124
Property and equipment, net	54,352	54,752
Deferred costs, net	35,472	35,585
Lease right-of-use assets	52,824	49,132
Goodwill	436,029	438,529
Intangible assets, net	119,165	134,601
Deferred income taxes, noncurrent	15,689	11,870
Other long-term assets	17,113	16,184
Total assets	2,583,641	2,271,777
Current liabilities:
Accounts payable	21,324	19,420
Accrued compensation and benefits	28,906	25,619
Accrued expenses and other current liabilities	22,391	21,620
Income tax payable	2,555	5,613
Deferred revenue	331,166	468,887
Lease liabilities	11,050	10,013
Total current liabilities	417,392	551,172
Deferred income taxes, noncurrent	1,004	2,417
Lease liabilities, noncurrent	47,965	44,815
Other long-term liabilities	10,901	7,779
Total liabilities	477,262	606,183
Commitments and contingencies
Stockholders’ equity:
Additional paid-in capital	906,137	745,475
Accumulated other comprehensive income	3,502	460
Retained earnings	1,196,738	919,658
Total stockholders’ equity	2,106,379	1,665,594
Total liabilities and stockholders’ equity	2,583,641	2,271,777
Class A common stock
Stockholders’ equity:
Common stock	2	1
Class B common stock
Stockholders’ equity:
Common stock	$ 0	$ 0

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Allowance for doubtful accounts	$ 516	$ 617
Class A common stock
Common stock, par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	800,000,000	800,000,000
Common stock, shares issued (in shares)	136,192,277	133,892,725
Common stock, shares outstanding (in shares)	136,192,277	133,892,725
Class B common stock
Common stock, par value (in usd per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	190,000,000	190,000,000
Common stock, shares issued (in shares)	15,091,251	15,202,858
Common stock, shares outstanding (in shares)	15,091,251	15,202,858

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Revenues:
Total revenues		$ 377,519	$ 280,921	$ 1,068,308	$ 792,573
Cost of revenues:
Total cost of revenues	[1]	102,997	73,329	295,081	209,050
Gross profit		274,522	207,592	773,227	583,523
Operating expenses:
Research and development	[1]	79,992	52,575	212,282	148,694
Sales and marketing	[1]	57,982	45,524	172,909	130,962
General and administrative	[1]	35,243	28,693	109,085	78,042
Total operating expenses	[1]	173,217	126,792	494,276	357,698
Operating income		101,305	80,800	278,951	225,825
Other income, net		3,455	9,141	9,750	22,634
Income before income taxes		104,760	89,941	288,701	248,459
Provision for income taxes		7,801	7,696	11,621	13,523
Net income		96,959	82,245	277,080	234,936
Net income, basic and diluted		$ 96,959	$ 82,245	$ 277,080	$ 234,936
Net income per share:
Basic (in usd per share)		$ 0.64	$ 0.56	$ 1.84	$ 1.59
Diluted (in usd per share)		$ 0.60	$ 0.52	$ 1.73	$ 1.49
Weighted-average shares used to compute net income per share:
Basic (in shares)		150,993	148,157	150,322	147,467
Diluted (in shares)		161,711	158,750	160,517	158,124
Other comprehensive income:
Net change in unrealized gain on available-for-sale investments		$ (1,230)	$ 753	$ 1,198	$ 2,176
Net change in cumulative foreign currency translation loss		(1,438)	(487)	1,844	(2,931)
Comprehensive income		94,291	82,511	280,122	234,181
Subscription services
Revenues:
Total revenues		302,938	226,760	856,675	642,187
Cost of revenues:
Total cost of revenues	[1]	45,845	31,964	132,457	93,822
Professional services and other
Revenues:
Total revenues		74,581	54,161	211,633	150,386
Cost of revenues:
Total cost of revenues	[1]	$ 57,152	$ 41,365	$ 162,624	$ 115,228

[1]	(1) Includes stock-based compensation as follows: Cost of revenues: Cost of subscription services $ 1,149 $ 560 $ 3,700 $ 1,528 Cost of professional services and other 7,510 4,825 19,902 12,261 Research and development 17,685 9,899 45,523 25,732 Sales and marketing 10,711 6,882 30,089 19,207 General and administrative 11,918 7,155 36,032 19,719 Total stock-based compensation $ 48,973 $ 29,321 $ 135,246 $ 78,447

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Total stock-based compensation	$ 48,973	$ 29,321	$ 135,246	$ 78,447
Cost of subscription services
Total stock-based compensation	1,149	560	3,700	1,528
Cost of professional services and other
Total stock-based compensation	7,510	4,825	19,902	12,261
Research and development
Total stock-based compensation	17,685	9,899	45,523	25,732
Sales and marketing
Total stock-based compensation	10,711	6,882	30,089	19,207
General and administrative
Total stock-based compensation	$ 11,918	$ 7,155	$ 36,032	$ 19,719

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Class A & B common stock	Additional paid-in capital	Retained earnings	Retained earningsCumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income
Beginning balance (in shares) at Jan. 31, 2019			146,190,079
Beginning balance at Jan. 31, 2019	$ 1,237,749	$ (657)	$ 1	$ 617,623	$ 619,197	$ (657)	$ 928
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			1,225,746
Issuance of common stock upon exercise of stock options	8,503			8,503
Issuance of common stock upon vesting of restricted stock units (in shares)			944,996
Issuance of common stock upon vesting of restricted stock units	0
Stock-based compensation expense	78,789			78,789
Other comprehensive income	(755)						(755)
Net income	234,936				234,936
Ending balance (in shares) at Oct. 31, 2019			148,360,821
Ending balance at Oct. 31, 2019	1,558,565		$ 1	704,915	853,476		173
Beginning balance (in shares) at Jul. 31, 2019			147,848,634
Beginning balance at Jul. 31, 2019	1,445,017		$ 1	673,878	771,231		(93)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			211,154
Issuance of common stock upon exercise of stock options	1,588			1,588
Issuance of common stock upon vesting of restricted stock units (in shares)			301,033
Issuance of common stock upon vesting of restricted stock units	0
Stock-based compensation expense	29,449			29,449
Other comprehensive income	266						266
Net income	82,245				82,245
Ending balance (in shares) at Oct. 31, 2019			148,360,821
Ending balance at Oct. 31, 2019	1,558,565		$ 1	704,915	853,476		173
Beginning balance (in shares) at Jan. 31, 2020			149,095,583
Beginning balance at Jan. 31, 2020	$ 1,665,594		$ 1	745,475	919,658		460
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,407,370		1,407,370
Issuance of common stock upon exercise of stock options	$ 25,209		$ 1	25,208
Issuance of common stock upon vesting of restricted stock units (in shares)			780,575
Issuance of common stock upon vesting of restricted stock units	0
Stock-based compensation expense	135,454			135,454
Other comprehensive income	3,042						3,042
Net income	277,080				277,080
Ending balance (in shares) at Oct. 31, 2020			151,283,528
Ending balance at Oct. 31, 2020	2,106,379		$ 2	906,137	1,196,738		3,502
Beginning balance (in shares) at Jul. 31, 2020			150,739,850
Beginning balance at Jul. 31, 2020	1,956,727		$ 2	850,776	1,099,779		6,170
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			300,999
Issuance of common stock upon exercise of stock options	6,180			6,180
Issuance of common stock upon vesting of restricted stock units (in shares)			242,679
Issuance of common stock upon vesting of restricted stock units	0
Stock-based compensation expense	49,181			49,181
Other comprehensive income	(2,668)						(2,668)
Net income	96,959				96,959
Ending balance (in shares) at Oct. 31, 2020			151,283,528
Ending balance at Oct. 31, 2020	$ 2,106,379		$ 2	$ 906,137	$ 1,196,738		$ 3,502

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Cash flows from operating activities
Net income	$ 96,959	$ 82,245	$ 277,080	$ 234,936
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,525	3,845	22,720	11,626
Reduction of operating lease right-of-use assets	3,322	1,798	9,411	5,016
Accretion of discount on short-term investments	1,203	(722)	1,688	(2,996)
Stock-based compensation	48,973	29,321	135,246	78,447
Amortization of deferred costs	5,350	4,832	15,425	14,524
Deferred income taxes	(1,894)	432	(3,532)	1,771
Loss (Gain) on foreign currency from mark-to-market derivative	19	(74)	14	(112)
Bad debt (recovery) expense	(181)	270	(60)	(42)
Changes in operating assets and liabilities:
Accounts receivable	37,448	28,319	206,214	186,633
Unbilled accounts receivable	(16,585)	(9,515)	(20,418)	(12,777)
Deferred costs	(6,177)	(4,500)	(15,312)	(13,528)
Income taxes payable	4,538	3,909	(453)	4,858
Prepaid expenses and other current and long-term assets	8,195	5,610	(2,937)	1,513
Accounts payable	3,060	1,253	(456)	1,216
Accrued expenses and other current liabilities	1,541	(1,682)	4,357	231
Deferred revenue	(90,291)	(78,326)	(137,980)	(105,637)
Operating lease liabilities	(3,229)	(1,625)	(8,496)	(5,143)
Other long-term liabilities	(4,373)	(3,886)	384	(2,270)
Net cash provided by operating activities	95,403	61,504	482,895	398,266
Cash flows from investing activities
Purchases of short-term investments	(417,898)	(190,695)	(874,465)	(628,784)
Maturities and sales of short-term investments	158,628	194,661	528,194	571,398
Long-term assets	(3,316)	(1,237)	(8,456)	(4,228)
Net cash (used in) provided by investing activities	(262,586)	2,729	(354,727)	(61,614)
Cash flows from financing activities
Changes in lease liabilities - finance leases	79	(241)	(420)	(729)
Proceeds from exercise of common stock options	6,186	1,607	25,245	8,618
Net cash provided by financing activities	6,265	1,366	24,825	7,889
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(599)	(487)	2,683	(2,931)
Net change in cash, cash equivalents, and restricted cash	(161,517)	65,112	155,676	341,610
Cash, cash equivalents, and restricted cash at beginning of period	796,990	828,676	479,797	552,178
Cash, cash equivalents, and restricted cash at end of period	635,473	893,788	635,473	893,788
Cash, cash equivalents, and restricted cash at end of period:
Cash, cash equivalents, and restricted cash at end of period	635,473	893,788	635,473	893,788
Supplemental disclosures of other cash flow information:
Cash paid for income taxes, net of refunds	2,198	1,739	17,153	5,004
Excess tax benefits from employee stock plans	17,329	8,931	59,067	39,509
Non-cash investing activities:
Changes in accounts payable and accrued expenses related to property and equipment purchases	$ 697	$ 109	$ 1,471	$ (428)

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	9 Months Ended
Summary of Business and Significant Accounting Policies	Oct. 31, 2020
Accounting Policies [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Description of Business Veeva is the leading provider of industry cloud solutions for the global life sciences industry. We were founded in 2007 on the premise that industry-specific cloud solutions could best address the operating challenges and regulatory requirements of life sciences companies. Our solutions are designed to meet the unique needs of our customers and their most strategic business functions - from research and development (R&D) to commercialization. Our solutions are designed to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our commercial solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. We also bring the benefits of our content and data management solutions to a set of customers outside of life sciences in three regulated industries: consumer goods, chemicals, and cosmetics. Our fiscal year end is January 31. Principles of Consolidation and Basis of Presentation These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, filed on March 30, 2020. Except for the change in certain policies upon adoption of the new accounting standards in Fiscal 2021, there have been no changes to our significant accounting policies described in the annual report that have had a material impact on our condensed consolidated financial statements and related notes. The unaudited condensed consolidated balance sheet as of January 31, 2020 included herein was derived from the audited financial statements as of that date. These unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly our financial position, results of operations, comprehensive income, and cash flows for the interim periods but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2021 or any other period. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations; • the determination of the period of benefit for amortization of deferred costs; and • the fair value of assets acquired and liabilities assumed for business combinations. As future events cannot be determined with precision, actual results could differ significantly from those estimates. Revenue Recognition We derive our revenues primarily from subscription services and professional services. Subscription services revenues consist of fees from customers accessing our cloud-based software solutions and fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, data services, training, and managed services related to our solutions. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services. We determine revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, we satisfy a performance obligation. Our subscription services agreements are generally non-cancelable during the term, although customers typically have the right to terminate their agreements for cause in the event of material breach. Subscription Services Revenues Subscription services revenues are recognized ratably over the respective non-cancelable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software. Professional Services and Other Revenues The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Data services and training revenues are generally recognized as the services are performed. Contracts with Multiple Performance Obligations Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography. New Accounting Pronouncements Adopted in Fiscal 2021 Cloud Computing Arrangements In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ” (Topic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new standard requires capitalized costs to be amortized on a straight-line basis generally over the term of the arrangement, and the financial statement presentation for these capitalized costs would be the same as that of the fees related to the hosting arrangements. We adopted this standard on a prospective basis as of February 1, 2020 and it did not have a material impact on our condensed consolidated financial statements. Credit Losses In June 2016, the Financial Accounting Standards Board, or FASB, issued ASU 2016-13, including subsequent amendments, regarding “ Measurement of Credit Losses on Financial Instruments ” (Topic 326), which modifies the accounting methodology for most financial instruments. The guidance establishes a new “expected loss model” that requires entities to estimate current expected credit losses on financial instruments by using all practical and relevant information. For trade receivables and other financial assets, we are required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Additionally, any expected credit losses are to be reflected as allowances rather than reductions in the amortized cost of available-for-sale debt securities. We adopted this standard on a modified retrospective basis as of February 1, 2020. The adoption of this standard did not result in any cumulative effect adjustment on our condensed consolidated financial statements.

Acquisitions

Acquisitions	9 Months Ended
Acquisitions	Oct. 31, 2020
Business Combinations [Abstract]
Acquisitions	Acquisitions Crossix On November 1, 2019, we acquired 100% ownership of Crossix in exchange for total consideration of $428 million, which includes the impact of adjustments to purchase price associated with the cash and net working capital of the acquired entity at close. In addition, we granted certain Crossix employees equity retention awards valued at approximately $120 million in the aggregate, which will be expensed as share-based compensation over the remaining service period. We have finalized our purchase accounting for the acquisition. Crossix brings Veeva additional depth in patient data and data analytics. Crossix's existing data analytics offerings are complementary to our existing Commercial Cloud offerings, and we are utilizing the Crossix Data Platform to build Veeva Data Cloud, our longitudinal patient and prescriber data offering. The following unaudited pro forma information presents the combined results of operations for the periods presented as if the acquisition had been completed on February 1, 2019, the beginning of the comparable prior annual reporting period. The unaudited pro forma results include the amortization associated with estimates for the purchased intangible assets and stock-based compensation expense associated with the retention awards granted. The unaudited pro forma results do not reflect any cost saving synergies from operating efficiencies or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these unaudited pro forma results are presented for information purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations (in thousands): Three months ended Nine months ended October 31, 2019 (Unaudited) Pro forma revenues $ 298,375 $ 841,989 Pro forma net income $ 65,998 $ 207,238 Pro forma net income per share: Basic $ 0.45 $ 1.41 Diluted $ 0.42 $ 1.31 Physicians World On November 7, 2019, we completed our acquisition of Physicians World in exchange for total cash consideration of $41 million, which includes the impact of adjustments to purchase price associated with the cash and net working capital of the acquired entity at close. In addition, we granted certain Physicians World employees equity retention awards valued at approximately $15 million in the aggregate. The acquisition of Physicians World makes it easier for our customers to get industry leading cloud software and services from a single vendor. Pro forma results of operations have not been presented for the three and nine months ended October 31, 2020 because the effect of this acquisition was not material to our condensed consolidated financial statements.

Short-Term Investments

Short-Term Investments	9 Months Ended
Short-Term Investments	Oct. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Short-Term Investments	Short-Term Investments At October 31, 2020, short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 15,600 $ 13 $ (1) $ 15,612 Asset-backed securities 130,733 821 (10) 131,544 Commercial paper 58,602 35 (1) 58,636 Corporate notes and bonds 414,837 2,528 (184) 417,181 Foreign government bonds 32,011 33 (17) 32,027 U.S. agency obligations 52,751 71 — 52,822 U.S. treasury securities 247,505 843 (3) 248,345 Total available-for-sale securities $ 952,039 $ 4,344 $ (216) $ 956,167 At January 31, 2020, short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 3,500 $ 3 $ — $ 3,503 Asset-backed securities 100,419 396 (1) 100,814 Commercial paper 19,965 5 (1) 19,969 Corporate notes and bonds 234,664 1,552 (2) 236,214 Foreign government bonds 3,397 10 — 3,407 U.S. treasury securities 245,509 599 — 246,108 Total available-for-sale securities $ 607,454 $ 2,565 $ (4) $ 610,015 The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands): October 31, January 31, Due in one year or less $ 434,612 $ 247,592 Due in greater than one year 521,555 362,423 Total $ 956,167 $ 610,015 The following table shows the fair values of these available-for-sale securities, which have been in an unrealized loss position for less than 12 months, aggregated by investment category as of October 31, 2020 (in thousands): Fair value Gross unrealized losses Certificates of deposits $ 2,999 $ (1) Asset-backed securities 11,771 (10) Commercial paper 13,329 (1) Corporate notes and bonds 154,408 (184) Foreign government bonds 24,293 (16) U.S. treasury securities 21,984 (3) The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months, aggregated by investment category as of January 31, 2020 (in thousands): Fair value Gross unrealized losses Asset-backed securities $ 2,623 $ (1) Commercial paper 5,589 (1) Corporate notes and bonds 9,105 (2) We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high credit quality of our investments. We intend to hold our securities to maturity and it is unlikely that they would be sold before their cost bases are recovered.

Deferred Costs

Deferred Costs	9 Months Ended
Deferred Costs	Oct. 31, 2020
Deferred Costs [Abstract]
Deferred Costs	Deferred CostsDeferred costs, which consist primarily of deferred sales commissions, were $35 million and $36 million as of October 31, 2020 and January 31, 2020, respectively. Amortization expense for the deferred costs included in sales and marketing expenses in the condensed consolidated statements of comprehensive income was $5 million and $15 million for the three and nine months ended October 31, 2020, respectively and $5 million and $15 million for the three and nine months ended October 31, 2019, respectively. There have been no impairment losses recorded in relation to the costs capitalized for any period presented.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
Property and Equipment, Net	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consists of the following as of the dates shown (in thousands): October 31, January 31, Land $ 3,040 $ 3,040 Building 20,984 20,984 Land improvements and building improvements 22,392 22,392 Equipment and computers 10,348 11,066 Furniture and fixtures 13,218 12,849 Leasehold improvements 11,856 9,385 Construction in progress 1,943 386 83,781 80,102 Less accumulated depreciation (29,429) (25,350) Total property and equipment, net $ 54,352 $ 54,752 Total depreciation expense was $2 million and $7 million for the three and nine months ended October 31, 2020, respectively, and $2 million and $6 million for the three and nine months ended October 31, 2019, respectively. Land is not depreciated.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
Goodwill and Intangible Assets	Oct. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill was $436 million and $439 million as of October 31, 2020 and January 31, 2020, respectively. The following schedule presents the details of intangible assets as of October 31, 2020 (dollar amounts in thousands): October 31, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,180 $ (7,422) $ 18,758 5.0 Customer relationships 110,643 (24,983) 85,660 8.3 Trade name/Trademarks 13,900 (3,341) 10,559 4.0 Other intangibles 20,453 (16,265) 4,188 5.4 $ 171,176 $ (52,011) $ 119,165 The following schedule presents the details of intangible assets as of January 31, 2020 (dollar amounts in thousands): January 31, 2020 Gross Accumulated Net Remaining Existing technology $ 26,380 $ (4,808) $ 21,572 5.8 Customer relationships 111,443 (17,575) 93,868 9.0 Trade name/Trademarks 13,900 (720) 13,180 4.7 Other intangibles 22,947 (16,966) 5,981 5.0 $ 174,670 $ (40,069) $ 134,601 Amortization expense associated with intangible assets was $5 million and $15 million for the three and nine months ended October 31, 2020, respectively, and $2 million and $5 million for the three and nine months ended October 31, 2019, respectively. As of October 31, 2020, the estimated amortization expense for intangible assets, for the next five years and thereafter is as follows (in thousands): Period Estimated Remaining for Fiscal 2021 $ 4,570 Fiscal 2022 18,163 Fiscal 2023 18,163 Fiscal 2024 18,160 Fiscal 2025 17,417 Thereafter 42,692 Total $ 119,165

Accrued Expenses

Accrued Expenses	9 Months Ended
Accrued Expenses	Oct. 31, 2020
Payables and Accruals [Abstract]
Accrued Expenses	Accrued Expenses Accrued expenses consisted of the following as of the dates shown (in thousands): October 31, January 31, Accrued commissions $ 6,995 $ 8,951 Accrued bonus 4,433 4,329 Accrued vacation 5,308 3,921 Payroll tax payable 9,647 7,353 Accrued other compensation and benefits 2,523 1,065 Total accrued compensation and benefits $ 28,906 $ 25,619 Accrued fees payable to salesforce.com $ 6,255 $ 5,787 Taxes payable 3,899 4,914 Accrued third-party professional services subcontractors' fees 1,507 1,338 Other accrued expenses 10,730 9,581 Total accrued expenses and other current liabilities $ 22,391 $ 21,620

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The carrying amounts of accounts receivable and other current assets, accounts payable, and accrued liabilities approximate their fair value due to their short-term nature. Financial assets and liabilities recorded at fair value in the condensed consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly related to the amount of subjectivity associated with the inputs to the valuation of these assets or liabilities are as follows: Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Financial assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires management to make judgments and considers factors specific to the asset or liability. The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of October 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 193,054 $ — $ 193,054 Corporate notes and bonds — 1,200 1,200 Short-term investments: Certificates of deposits — 15,612 15,612 Asset-backed securities — 131,544 131,544 Commercial paper — 58,636 58,636 Corporate notes and bonds — 417,181 417,181 Foreign government bonds — 32,027 32,027 U.S. agency obligations — 52,822 52,822 U.S. treasury securities — 248,345 248,345 Foreign currency derivative contracts — 85 85 Total $ 193,054 $ 957,452 $ 1,150,506 Liabilities Foreign currency derivative contracts $ — $ 65 $ 65 Total $ — $ 65 $ 65 The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of January 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 24,107 $ — $ 24,107 Commercial paper — 1,616 1,616 Corporate notes and bonds — 2,245 2,245 Short-term investments: Certificates of deposits — 3,503 3,503 Asset-backed securities — 100,815 100,815 Commercial paper — 19,969 19,969 Corporate notes and bonds — 236,214 236,214 Foreign government bonds — 3,407 3,407 U.S. treasury securities — 246,107 246,107 Foreign currency derivative contracts — 75 75 Total $ 24,107 $ 613,951 $ 638,058 Liabilities Foreign currency derivative contracts $ — $ 42 $ 42 Total $ — $ 42 $ 42 We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. The valuation techniques used to measure the fair value of financial instruments having Level 2 inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs). Balance Sheet Hedges We enter into foreign currency forward contracts (the “Forward Contracts”) in order to hedge our foreign currency exposure. We account for derivative instruments at fair value with changes in the fair value recorded as a component of other income, net in our condensed consolidated statements of comprehensive income. Cash flows from such forward contracts are classified as operating activities. The realized foreign currency loss we recognized was immaterial for the three months ended October 31, 2020 and the loss was $1 million for the nine months ended October 31, 2020. The realized foreign currency gains and losses were immaterial for the three and nine months ended October 31, 2019. The fair value of our outstanding derivative instruments is summarized below (in thousands): October 31, January 31, Notional amount of foreign currency derivative contracts $ 10,409 $ 7,304 Fair value of foreign currency derivative contracts 10,390 7,271 Details on outstanding balance sheet hedges are presented below as of the date shown below (in thousands): Derivatives not designated as hedging instruments Balance sheet location October 31, January 31, Derivative Assets Foreign currency derivative contracts Prepaid expenses and other current assets $ 85 $ 75 Derivative Liabilities Foreign currency derivative contracts Accrued expenses $ 65 $ 42

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended October 31, 2020 and 2019, our effective tax rates were 7.4% and 8.6%, respectively. During the three months ended October 31, 2020 as compared to the prior year period, our effective tax rate decreased primarily due to the increase in excess tax benefits related to equity compensation. We recognized such excess tax benefits in our provision for income taxes of $17 million and $9 million for the three months ended October 31, 2020 and 2019, respectively. For the nine months ended October 31, 2020 and 2019, our effective tax rates were 4.0% and 5.4%, respectively. During the nine months ended October 31, 2020 as compared to the prior year period, our effective tax rate decreased primarily due to the increase in excess tax benefits related to equity compensation. We recognized such excess tax benefits in our provision for income taxes of $59 million and $40 million for the nine months ended October 31, 2020 and 2019, respectively.

Deferred Revenue, Performance O

Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable	9 Months Ended
	Oct. 31, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable	Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable Of the beginning deferred revenue balance for the respective periods, we recognized $232 million and $409 million of subscription services revenue during the three and nine months ended October 31, 2020, respectively, and $178 million and $311 million of subscription services revenue during the three and nine months ended October 31, 2019, respectively. Professional services revenue recognized in the same periods from deferred revenue balances at the beginning of the respective periods was immaterial. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancelable amounts that will be invoiced and recognized as revenues in future periods. We applied the practical expedient in accordance with ASU 2014-09, “ Revenue from Contracts with Customers ” (Topic 606) to exclude the amounts related to professional services contracts as these contracts generally have a remaining duration of one year or less. As of October 31, 2020, approximately $772 million of revenue is expected to be recognized from remaining performance obligations for subscription services contracts. We expect to recognize revenue on approximately 73% of these remaining performance obligations over the next 12 months, with the balance recognized thereafter. Unbilled Accounts Receivable Unbilled accounts receivable consists of (i) a receivable primarily for the revenue recognized for professional services performed but not yet billed, which were $23 million and $18 million as of October 31, 2020 and January 31, 2020, respectively, and (ii) a contract asset primarily for revenue recognized from non-cancelable, multi-year orders in which fees increase annually but for which we are not contractually able to invoice until a future period, which were $30 million and $15 million as of October 31, 2020 and January 31, 2020, respectively.

Leases

Leases	9 Months Ended
Leases	Oct. 31, 2020
Leases [Abstract]
Leases	Leases We have operating and finance leases for corporate offices, data centers, and certain equipment. Our leases have various expiration dates through 2030, some of which include options to extend the leases for up to nine years. Additionally, we are the sublessor for certain office space. Our sublease income for the three and nine months ended October 31, 2020 and 2019 was immaterial. For the three and nine months ended October 31, 2020, our operating lease expense was $3 million and $9 million, respectively. For the three and nine months ended October 31, 2019, our operating lease expense was $2 million and $5 million, respectively. Our finance lease expense was immaterial for the three and nine months ended October 31, 2020 and 2019. Supplemental cash flow information related to leases was as follows (in thousands): Nine months ended 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 8,149 $ 5,131 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,937 11,656 Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): October 31, 2020 October 31, 2019 Operating Leases Lease right-of-use assets $ 52,824 $ 24,055 Lease liabilities $ 10,429 $ 6,401 Lease liabilities, noncurrent 47,965 19,261 Total operating lease liabilities $ 58,394 $ 25,662 Finance Leases Property and equipment, at cost $ 1,738 $ 1,738 Accumulated depreciation (1,738) (978) Property and equipment, net $ — $ 760 Lease liabilities $ 621 $ 1,029 Lease liabilities, noncurrent — 621 Total finance lease liabilities $ 621 $ 1,650 Weighted Average Remaining Lease Term Operating leases 7.0 years 5.2 years Finance leases 0.6 years 1.6 years Weighted Average Discount Rate Operating leases 4.0 % 4.3 % Finance leases 4.3 % 4.3 % As of October 31, 2020, remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 3,192 $ 269 Fiscal 2022 11,535 359 Fiscal 2023 9,968 — Fiscal 2024 8,897 — Fiscal 2025 6,540 — Thereafter 27,100 — Total lease payments 67,232 628 Less imputed interest (8,838) (7) Total $ 58,394 $ 621
Leases	Leases We have operating and finance leases for corporate offices, data centers, and certain equipment. Our leases have various expiration dates through 2030, some of which include options to extend the leases for up to nine years. Additionally, we are the sublessor for certain office space. Our sublease income for the three and nine months ended October 31, 2020 and 2019 was immaterial. For the three and nine months ended October 31, 2020, our operating lease expense was $3 million and $9 million, respectively. For the three and nine months ended October 31, 2019, our operating lease expense was $2 million and $5 million, respectively. Our finance lease expense was immaterial for the three and nine months ended October 31, 2020 and 2019. Supplemental cash flow information related to leases was as follows (in thousands): Nine months ended 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 8,149 $ 5,131 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,937 11,656 Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): October 31, 2020 October 31, 2019 Operating Leases Lease right-of-use assets $ 52,824 $ 24,055 Lease liabilities $ 10,429 $ 6,401 Lease liabilities, noncurrent 47,965 19,261 Total operating lease liabilities $ 58,394 $ 25,662 Finance Leases Property and equipment, at cost $ 1,738 $ 1,738 Accumulated depreciation (1,738) (978) Property and equipment, net $ — $ 760 Lease liabilities $ 621 $ 1,029 Lease liabilities, noncurrent — 621 Total finance lease liabilities $ 621 $ 1,650 Weighted Average Remaining Lease Term Operating leases 7.0 years 5.2 years Finance leases 0.6 years 1.6 years Weighted Average Discount Rate Operating leases 4.0 % 4.3 % Finance leases 4.3 % 4.3 % As of October 31, 2020, remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 3,192 $ 269 Fiscal 2022 11,535 359 Fiscal 2023 9,968 — Fiscal 2024 8,897 — Fiscal 2025 6,540 — Thereafter 27,100 — Total lease payments 67,232 628 Less imputed interest (8,838) (7) Total $ 58,394 $ 621

Stockholders' Equity

Stockholders' Equity	9 Months Ended
Stockholders' Equity	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
Stockholders' Equity	Stockholders’ Equity Stock Option Activity A summary of stock option activity for the nine months ended October 31, 2020 is as follows: Number of shares Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value Options outstanding at January 31, 2020 13,448,026 $ 40.64 5.4 $ 1,426,502,005 Options granted 1,368,632 177.44 Options exercised (1,407,370) 17.91 Options forfeited/cancelled (195,630) 121.20 Options outstanding at October 31, 2020 13,213,658 $ 55.83 5.2 $ 2,830,945,659 Options vested and exercisable at October 31, 2020 6,756,111 $ 14.19 3.0 $ 1,728,597,328 Options vested and exercisable at October 31, 2020 and expected to vest thereafter 13,213,658 $ 55.83 5.2 $ 2,830,945,659 The options granted during the nine months ended October 31, 2020 were predominantly made in connection with our annual performance review cycle. The weighted average grant-date fair value of options granted was $105.38 and $70.44 for the three and nine months ended October 31, 2020. As of October 31, 2020, there was $230 million in unrecognized compensation cost related to unvested stock options granted under the 2012 Equity Incentive Plan and 2013 Equity Incentive Plan. This cost is expected to be recognized over a weighted average period of 3.4 years. As of October 31, 2020, we had authorized and unissued shares of common stock sufficient to satisfy exercises of stock options. The total intrinsic value of options exercised was approximately $81 million and $266 million for the three and nine months ended October 31, 2020, respectively. Restricted Stock Units A summary of restricted stock unit (RSU) activity for the nine months ended October 31, 2020 is as follows: Unreleased restricted stock units Weighted average grant date fair value Balance at January 31, 2020 1,818,622 $ 95.23 RSUs granted 428,503 179.95 RSUs vested (780,989) 95.06 RSUs forfeited/cancelled (97,221) 111.42 Balance at October 31, 2020 1,368,915 120.63 As of October 31, 2020, there was a total of $137 million in unrecognized compensation cost related to unvested RSUs. This cost is expected to be recognized over a weighted-average period of approximately 2.4 years. The total intrinsic value of RSUs vested was $68 million and $167 million for the three and nine months ended October 31, 2020, respectively. Stock-Based Compensation The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Volatility 39 % - 40% 41% 39 % - 41% 41% Expected term (in years) 6.25 6.25 6.25 - 7.25 5.75 - 6.35 Risk-free interest rate 0.33 % - 0.45% 1.39% - 1.64% 0.33 % - 1.43% 1.39 % - 2.52% Dividend yield —% —% —% —%

Net Income per Share

Net Income per Share	9 Months Ended
Net Income per Share	Oct. 31, 2020
Earnings Per Share [Abstract]
Net Income per Share	Net Income per Share Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock are determined using the treasury stock method. The computation of fully diluted net income per share of Class A common stock assumes the conversion from Class B common stock, while the fully diluted net income per share of Class B common stock does not assume the conversion of those shares. The numerators and denominators of the basic and diluted net income per share computations for our common stock are calculated as follows (in thousands, except per share data): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Class A Class B Class A Class B Class A Class B Class A Class B Basic Numerator Net income, basic $ 87,262 $ 9,697 $ 73,120 $ 9,125 $ 249,155 $ 27,925 $ 206,862 $ 28,074 Denominator Weighted average shares used in computing net income per share, basic 135,892 15,101 131,720 16,437 135,172 15,150 129,845 17,622 Net income per share, basic $ 0.64 $ 0.64 $ 0.56 $ 0.56 $ 1.84 $ 1.84 $ 1.59 $ 1.59 Diluted Numerator Net income, basic $ 87,262 $ 9,697 $ 73,120 $ 9,125 $ 249,155 $ 27,925 $ 206,862 $ 28,074 Reallocation as a result of conversion of Class B to Class A common stock: Net income, basic 9,697 — 9,125 — 27,925 — 28,074 — Reallocation of net income to Class B common stock — 5,784 — 4,879 — 15,825 — 13,942 Net income, diluted $ 96,959 $ 15,481 $ 82,245 $ 14,004 $ 277,080 $ 43,750 $ 234,936 $ 42,016 Denominator Number of shares used for basic net income per share computation 135,892 15,101 131,720 16,437 135,172 15,150 129,845 17,622 Conversion of Class B to Class A common stock 15,101 — 16,437 — 15,150 — 17,622 — Effect of potentially dilutive common shares 10,718 10,718 10,593 10,593 10,195 10,195 10,657 10,657 Weighted average shares used in computing net income per share, diluted 161,711 25,819 158,750 27,030 160,517 25,345 158,124 28,279 Net income per share, diluted $ 0.60 $ 0.60 $ 0.52 $ 0.52 $ 1.73 $ 1.73 $ 1.49 $ 1.49 Potential common share equivalents excluded where the inclusion would be anti-dilutive are as follows: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive 85,099 1,362,085 997,236 1,037,362

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation IQVIA Litigation Matters Veeva OpenData and Veeva Network Action. On January 10, 2017, IQVIA Inc. (formerly Quintiles IMS Incorporated) and IMS Software Services, Ltd. (collectively, “IQVIA”) filed a complaint against us in the U.S. District Court for the District of New Jersey (IQVIA Inc. v. Veeva Systems Inc. (No. 2:17-cv-00177)) (“OpenData and Network Action”). In the complaint, IQVIA alleges that we have used unauthorized access to proprietary IQVIA data to improve our software and data products and that our software is designed to steal IQVIA trade secrets. IQVIA further alleges that we have intentionally gained unauthorized access to IQVIA proprietary information to gain an unfair advantage in marketing our products and that we have made false statements concerning IQVIA’s conduct and our data security capabilities. IQVIA asserts claims under both federal and state misappropriation of trade secret laws, federal false advertising law, and common law claims for unjust enrichment, tortious interference, and unfair trade practices. The complaint seeks declaratory and injunctive relief and unspecified monetary damages. On March 13, 2017, we filed our answer denying IQVIA's claims and filed counterclaims in the OpenData and Network Action. Our counterclaims allege that IQVIA has abused monopoly power as the dominant provider of data products for life sciences companies to exclude Veeva OpenData and Veeva Network from their respective markets. The counterclaims allege that IQVIA has engaged in various tactics to prevent customers from using our applications and has deliberately raised costs and difficulty for customers attempting to switch from IQVIA to our data products. As amended, our counterclaims assert federal and state antitrust claims, as well as claims under California’s Unfair Practices Act and common law claims for intentional interference with contractual relations, intentional interference with prospective economic advantage, and negligent misrepresentation. The counterclaims seek injunctive relief, monetary damages exceeding $200 million, and attorneys’ fees. On May 3, 2017, in lieu of filing an answer, IQVIA filed a motion to dismiss our counterclaims. On October 3, 2018, the court denied IQVIA’s motion to dismiss and allowed our antitrust claims to proceed. In addition, on December 3, 2018, we filed an amended answer and counterclaims. IQVIA filed its answer and affirmative defenses on December 21, 2018. On February 18, 2020, IQVIA filed a motion for sanctions against Veeva, seeking default judgment and dismissal and, in the alternative, a negative inference at trial. Veeva responded to the motion and on October 29, 2020, a hearing was held before the Special Master appointed to assist the court with discovery and pretrial disputes. No ruling has been issued. Discovery is currently in process. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of this action, and we are unable to make a meaningful estimate of the amount or range of gain or loss, if any, that could result from the OpenData and Network Action, we believe that IQVIA’s claims lack merit and that our counterclaims warrant injunctive relief and monetary damages for Veeva. Veeva Nitro Action. On July 17, 2019, IQVIA filed a lawsuit in the U.S. District Court for the District of New Jersey (IQVIA Inc. v. Veeva Systems Inc. (No. 2:19-cv-15517)) (“IQVIA Declaratory Action”) seeking a declaratory judgment that IQVIA is not liable to Veeva for disallowing use of IQVIA’s data products in Veeva Nitro or any later-introduced Veeva software products. The IQVIA Declaratory Action does not seek any monetary relief. On July 18, 2019, we filed a lawsuit against IQVIA in the U.S. District Court for the Northern District of California (Veeva Systems Inc. v. IQVIA Inc. (No. 3:19-cv-04137)) (“Veeva Nitro Action”), alleging that IQVIA engaged in anticompetitive conduct as to Veeva Nitro. Our complaint asserts federal and state antitrust claims, as well as claims under California’s Unfair Competition Law and common law claims for intentional interference with contractual relations and intentional interference with prospective economic advantage. The complaint seeks injunctive relief and monetary damages. IQVIA filed its answer and affirmative defenses on September 5, 2019. On September 26, 2019, the Northern District of California transferred the Veeva Nitro Action to the District of New Jersey. On March 24, 2020, we amended our complaint in the Veeva Nitro Action to include allegations of IQVIA’s anticompetitive conduct as to additional Veeva software applications, such as Veeva Andi, Veeva Align, and Veeva Vault MedComms; additional examples of IQVIA’s monopolistic behavior against Veeva Nitro; IQVIA’s unlawful access of Veeva’s proprietary software products; and a request for declaratory relief. IQVIA answered the amended complaint on May 22, 2020. On August 21, 2020, the District of New Jersey consolidated the Veeva Nitro Action and IQVIA Declaratory Action, and stayed both actions pending conclusion of the OpenData and Network Action. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of this action, we believe that our claims warrant injunctive and declaratory relief and monetary damages for Veeva and against IQVIA. Medidata Litigation Matter On January 26, 2017, Medidata Solutions, Inc. filed a complaint in the U.S. District Court for the Southern District of New York ( Medidata Solutions, Inc. v. Veeva Systems Inc. et al. (No. 1:17-cv-00589)) against us and five individual Veeva employees who previously worked for Medidata (“Individual Employees”). The complaint alleged that we induced and conspired with the Individual Employees to breach their employment agreements, including non-compete and confidentiality provisions, and to misappropriate Medidata’s confidential and trade secret information. The complaint sought declaratory and injunctive relief, unspecified monetary damages, and attorneys’ fees. Medidata has since amended its complaint twice, asserting the same claims with additional factual allegations, and has voluntarily dismissed the Individual Defendants without prejudice. Discovery is now completed. On April 24, 2020, Medidata filed a motion for partial summary judgment on its claims for trade secret misappropriation as well as several of Veeva’s affirmative defenses. On May 15, 2020, we filed a motion for summary judgment on all of Medidata’s claims. Briefing on the parties’ cross-motions is now complete and we are awaiting a ruling. No trial date has been set. While it is not possible at this time to predict with any degree of certainty the ultimate outcome of this action, and we are unable to make a meaningful estimate of the amount or range of loss, if any, that could result from any unfavorable outcome, we believe that Medidata’s claims lack merit. Other Litigation Matters From time to time, we may be involved in other legal proceedings and subject to claims incident to the ordinary course of business. Although the results of such legal proceedings and claims cannot be predicted with certainty, we believe we are not currently a party to any other legal proceedings, the outcome of which, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows or financial position. Regardless of the outcome, such proceedings can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained. Value-Added Reseller Agreement We have a value-added reseller agreement with salesforce.com, inc. for our use of the Salesforce1 Platform in combination with our developed technology to deliver certain of our multichannel CRM applications, including hosting infrastructure and data center operations provided by salesforce.com. The agreement, as amended, requires that we meet minimum order commitments of $500 million over the term of the agreement, which ends on September 1, 2025, including “true-up” payments if the orders we place with salesforce.com have not equaled or exceeded the following aggregate amounts within the timeframes indicated: (i) $250 million for the period from March 1, 2014 to September 1, 2020 and (ii) the full amount of $500 million by September 1, 2025. We have met our first minimum order requirement commitment of $250 million, and as of October 31, 2020, we remained obligated to pay fees of at least $78 million prior to September 1, 2025 in connection with this agreement.

Revenues by Product

Revenues by Product	9 Months Ended
Revenues by Product	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenues by Product	Revenues by Product Our industry cloud solutions are grouped into two key product areas—Veeva Commercial Cloud and Veeva Vault. Veeva Commercial Cloud is a suite of multichannel CRM applications, territory allocation and alignment applications, master data management applications, customer reference and key opinion leader data, data analytics, and other related services. Veeva Vault is a unified suite of cloud-based, enterprise content and data management applications. Total revenues consist of the following (in thousands): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Subscription services Veeva Commercial Cloud $ 152,466 $ 115,201 $ 439,858 $ 333,591 Veeva Vault 150,472 111,559 416,817 308,596 Total subscription services $ 302,938 $ 226,760 $ 856,675 $ 642,187 Professional services Veeva Commercial Cloud $ 29,115 $ 18,589 $ 83,109 $ 52,381 Veeva Vault 45,466 35,572 128,524 98,005 Total professional services $ 74,581 $ 54,161 $ 211,633 $ 150,386 Total revenues $ 377,519 $ 280,921 $ 1,068,308 $ 792,573

Information about Geographic Ar

Information about Geographic Areas	9 Months Ended
Information about Geographic Areas	Oct. 31, 2020
Segment Reporting [Abstract]
Information about Geographic Areas	Information about Geographic Areas We track and allocate revenues by principal geographic area rather than by individual country, which makes it impractical to disclose revenues for the United States or other specific foreign countries. We measure subscription services revenue primarily by the estimated location of the end users in each geographic area for Veeva Commercial Cloud and primarily by the estimated location of usage in each geographic area for Veeva Vault. We measure professional services revenue primarily by the location of the resources performing the professional services. Total revenues by geographic area were as follows for the periods shown below (in thousands): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Revenues by geography North America $ 218,110 $ 153,005 $ 614,101 $ 430,441 Europe 102,440 79,832 290,257 226,026 Asia Pacific 46,178 39,057 133,039 110,560 Rest of world (1) 10,791 9,027 30,911 25,546 Total revenues $ 377,519 $ 280,921 $ 1,068,308 $ 792,573 (1) Middle East, Africa, and Latin America Long-lived assets by geographic area are as follows as of the periods shown below (in thousands): October 31, January 31, Long-lived assets by geography North America $ 44,825 $ 51,334 Europe and rest of world 5,701 2,077 Asia Pacific 3,826 1,341 Total long-lived assets $ 54,352 $ 54,752

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Description of Business	Description of Business Veeva is the leading provider of industry cloud solutions for the global life sciences industry. We were founded in 2007 on the premise that industry-specific cloud solutions could best address the operating challenges and regulatory requirements of life sciences companies. Our solutions are designed to meet the unique needs of our customers and their most strategic business functions - from research and development (R&D) to commercialization. Our solutions are designed to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our commercial solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. We also bring the benefits of our content and data management solutions to a set of customers outside of life sciences in three regulated industries: consumer goods, chemicals, and cosmetics. Our fiscal year end is January 31.
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2020, filed on March 30, 2020. Except for the change in certain policies upon adoption of the new accounting standards in Fiscal 2021, there have been no changes to our significant accounting policies described in the annual report that have had a material impact on our condensed consolidated financial statements and related notes. The unaudited condensed consolidated balance sheet as of January 31, 2020 included herein was derived from the audited financial statements as of that date. These unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly our financial position, results of operations, comprehensive income, and cash flows for the interim periods but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2021 or any other period.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to: • the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations; • the determination of the period of benefit for amortization of deferred costs; and • the fair value of assets acquired and liabilities assumed for business combinations. As future events cannot be determined with precision, actual results could differ significantly from those estimates.
Revenue Recognition	Revenue Recognition We derive our revenues primarily from subscription services and professional services. Subscription services revenues consist of fees from customers accessing our cloud-based software solutions and fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, data services, training, and managed services related to our solutions. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services. We determine revenue recognition through the following steps: • Identification of the contract, or contracts, with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, we satisfy a performance obligation. Our subscription services agreements are generally non-cancelable during the term, although customers typically have the right to terminate their agreements for cause in the event of material breach. Subscription Services Revenues Subscription services revenues are recognized ratably over the respective non-cancelable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software. Professional Services and Other Revenues The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Data services and training revenues are generally recognized as the services are performed. Contracts with Multiple Performance Obligations Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography.
New Accounting Pronouncements Adopted in Fiscal 2021	New Accounting Pronouncements Adopted in Fiscal 2021 Cloud Computing Arrangements In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles-Goodwill and Other-Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract ” (Topic 350-40), which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new standard requires capitalized costs to be amortized on a straight-line basis generally over the term of the arrangement, and the financial statement presentation for these capitalized costs would be the same as that of the fees related to the hosting arrangements. We adopted this standard on a prospective basis as of February 1, 2020 and it did not have a material impact on our condensed consolidated financial statements. Credit Losses In June 2016, the Financial Accounting Standards Board, or FASB, issued ASU 2016-13, including subsequent amendments, regarding “ Measurement of Credit Losses on Financial Instruments ” (Topic 326), which modifies the accounting methodology for most financial instruments. The guidance establishes a new “expected loss model” that requires entities to estimate current expected credit losses on financial instruments by using all practical and relevant information. For trade receivables and other financial assets, we are required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Additionally, any expected credit losses are to be reflected as allowances rather than reductions in the amortized cost of available-for-sale debt securities. We adopted this standard on a modified retrospective basis as of February 1, 2020. The adoption of this standard did not result in any cumulative effect adjustment on our condensed consolidated financial statements.
Fair Value Measurements	Financial assets and liabilities recorded at fair value in the condensed consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly related to the amount of subjectivity associated with the inputs to the valuation of these assets or liabilities are as follows: Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Financial assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires management to make judgments and considers factors specific to the asset or liability.
Net Income per Share Attributable to Common Stockholders	Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock are determined using the treasury stock method. The computation of fully diluted net income per share of Class A common stock assumes the conversion from Class B common stock, while the fully diluted net income per share of Class B common stock does not assume the conversion of those shares.

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
Acquisitions (Tables)	Oct. 31, 2020
Business Combinations [Abstract]
Schedule of Pro Forma Information from Business Acquisition	Accordingly, these unaudited pro forma results are presented for information purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations (in thousands): Three months ended Nine months ended October 31, 2019 (Unaudited) Pro forma revenues $ 298,375 $ 841,989 Pro forma net income $ 65,998 $ 207,238 Pro forma net income per share: Basic $ 0.45 $ 1.41 Diluted $ 0.42 $ 1.31

Short-Term Investments (Tables)

Short-Term Investments (Tables)	9 Months Ended
Short-Term Investments (Tables)	Oct. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Schedule of Short-Term Investments	At October 31, 2020, short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 15,600 $ 13 $ (1) $ 15,612 Asset-backed securities 130,733 821 (10) 131,544 Commercial paper 58,602 35 (1) 58,636 Corporate notes and bonds 414,837 2,528 (184) 417,181 Foreign government bonds 32,011 33 (17) 32,027 U.S. agency obligations 52,751 71 — 52,822 U.S. treasury securities 247,505 843 (3) 248,345 Total available-for-sale securities $ 952,039 $ 4,344 $ (216) $ 956,167 At January 31, 2020, short-term investments consisted of the following (in thousands): Amortized cost Gross unrealized gains Gross unrealized losses Estimated fair value Available-for-sale securities: Certificates of deposits $ 3,500 $ 3 $ — $ 3,503 Asset-backed securities 100,419 396 (1) 100,814 Commercial paper 19,965 5 (1) 19,969 Corporate notes and bonds 234,664 1,552 (2) 236,214 Foreign government bonds 3,397 10 — 3,407 U.S. treasury securities 245,509 599 — 246,108 Total available-for-sale securities $ 607,454 $ 2,565 $ (4) $ 610,015 The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands): October 31, January 31, Due in one year or less $ 434,612 $ 247,592 Due in greater than one year 521,555 362,423 Total $ 956,167 $ 610,015
Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category	The following table shows the fair values of these available-for-sale securities, which have been in an unrealized loss position for less than 12 months, aggregated by investment category as of October 31, 2020 (in thousands): Fair value Gross unrealized losses Certificates of deposits $ 2,999 $ (1) Asset-backed securities 11,771 (10) Commercial paper 13,329 (1) Corporate notes and bonds 154,408 (184) Foreign government bonds 24,293 (16) U.S. treasury securities 21,984 (3) The following table shows the fair values of these available-for-sale securities, some of which have been in an unrealized loss position for more than 12 months, aggregated by investment category as of January 31, 2020 (in thousands): Fair value Gross unrealized losses Asset-backed securities $ 2,623 $ (1) Commercial paper 5,589 (1) Corporate notes and bonds 9,105 (2)

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
Property and Equipment, Net (Tables)	Oct. 31, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consists of the following as of the dates shown (in thousands): October 31, January 31, Land $ 3,040 $ 3,040 Building 20,984 20,984 Land improvements and building improvements 22,392 22,392 Equipment and computers 10,348 11,066 Furniture and fixtures 13,218 12,849 Leasehold improvements 11,856 9,385 Construction in progress 1,943 386 83,781 80,102 Less accumulated depreciation (29,429) (25,350) Total property and equipment, net $ 54,352 $ 54,752

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
Goodwill and Intangible Assets (Tables)	Oct. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Details of Intangible Assets	The following schedule presents the details of intangible assets as of October 31, 2020 (dollar amounts in thousands): October 31, 2020 Gross carrying amount Accumulated amortization Net Remaining useful life (in years) Existing technology $ 26,180 $ (7,422) $ 18,758 5.0 Customer relationships 110,643 (24,983) 85,660 8.3 Trade name/Trademarks 13,900 (3,341) 10,559 4.0 Other intangibles 20,453 (16,265) 4,188 5.4 $ 171,176 $ (52,011) $ 119,165 The following schedule presents the details of intangible assets as of January 31, 2020 (dollar amounts in thousands): January 31, 2020 Gross Accumulated Net Remaining Existing technology $ 26,380 $ (4,808) $ 21,572 5.8 Customer relationships 111,443 (17,575) 93,868 9.0 Trade name/Trademarks 13,900 (720) 13,180 4.7 Other intangibles 22,947 (16,966) 5,981 5.0 $ 174,670 $ (40,069) $ 134,601
Estimated Amortization Expense	As of October 31, 2020, the estimated amortization expense for intangible assets, for the next five years and thereafter is as follows (in thousands): Period Estimated Remaining for Fiscal 2021 $ 4,570 Fiscal 2022 18,163 Fiscal 2023 18,163 Fiscal 2024 18,160 Fiscal 2025 17,417 Thereafter 42,692 Total $ 119,165

Accrued Expenses (Tables)

Accrued Expenses (Tables)	9 Months Ended
Accrued Expenses (Tables)	Oct. 31, 2020
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following as of the dates shown (in thousands): October 31, January 31, Accrued commissions $ 6,995 $ 8,951 Accrued bonus 4,433 4,329 Accrued vacation 5,308 3,921 Payroll tax payable 9,647 7,353 Accrued other compensation and benefits 2,523 1,065 Total accrued compensation and benefits $ 28,906 $ 25,619 Accrued fees payable to salesforce.com $ 6,255 $ 5,787 Taxes payable 3,899 4,914 Accrued third-party professional services subcontractors' fees 1,507 1,338 Other accrued expenses 10,730 9,581 Total accrued expenses and other current liabilities $ 22,391 $ 21,620

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of October 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 193,054 $ — $ 193,054 Corporate notes and bonds — 1,200 1,200 Short-term investments: Certificates of deposits — 15,612 15,612 Asset-backed securities — 131,544 131,544 Commercial paper — 58,636 58,636 Corporate notes and bonds — 417,181 417,181 Foreign government bonds — 32,027 32,027 U.S. agency obligations — 52,822 52,822 U.S. treasury securities — 248,345 248,345 Foreign currency derivative contracts — 85 85 Total $ 193,054 $ 957,452 $ 1,150,506 Liabilities Foreign currency derivative contracts $ — $ 65 $ 65 Total $ — $ 65 $ 65 The following table presents the fair value hierarchy for financial assets measured at fair value on a recurring basis as of January 31, 2020 (in thousands): Level 1 Level 2 Total Assets Cash equivalents: Money market funds $ 24,107 $ — $ 24,107 Commercial paper — 1,616 1,616 Corporate notes and bonds — 2,245 2,245 Short-term investments: Certificates of deposits — 3,503 3,503 Asset-backed securities — 100,815 100,815 Commercial paper — 19,969 19,969 Corporate notes and bonds — 236,214 236,214 Foreign government bonds — 3,407 3,407 U.S. treasury securities — 246,107 246,107 Foreign currency derivative contracts — 75 75 Total $ 24,107 $ 613,951 $ 638,058 Liabilities Foreign currency derivative contracts $ — $ 42 $ 42 Total $ — $ 42 $ 42
Summary Fair Value of Outstanding Derivative Instruments	The fair value of our outstanding derivative instruments is summarized below (in thousands): October 31, January 31, Notional amount of foreign currency derivative contracts $ 10,409 $ 7,304 Fair value of foreign currency derivative contracts 10,390 7,271
Summary of Outstanding Balance Sheet Hedges	Details on outstanding balance sheet hedges are presented below as of the date shown below (in thousands): Derivatives not designated as hedging instruments Balance sheet location October 31, January 31, Derivative Assets Foreign currency derivative contracts Prepaid expenses and other current assets $ 85 $ 75 Derivative Liabilities Foreign currency derivative contracts Accrued expenses $ 65 $ 42

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Oct. 31, 2020
Leases [Abstract]
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (in thousands): Nine months ended 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 8,149 $ 5,131 Right-of-use assets obtained in exchange for lease obligations: Operating leases 8,937 11,656
Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows (in thousands, except lease term and discount rate): October 31, 2020 October 31, 2019 Operating Leases Lease right-of-use assets $ 52,824 $ 24,055 Lease liabilities $ 10,429 $ 6,401 Lease liabilities, noncurrent 47,965 19,261 Total operating lease liabilities $ 58,394 $ 25,662 Finance Leases Property and equipment, at cost $ 1,738 $ 1,738 Accumulated depreciation (1,738) (978) Property and equipment, net $ — $ 760 Lease liabilities $ 621 $ 1,029 Lease liabilities, noncurrent — 621 Total finance lease liabilities $ 621 $ 1,650 Weighted Average Remaining Lease Term Operating leases 7.0 years 5.2 years Finance leases 0.6 years 1.6 years Weighted Average Discount Rate Operating leases 4.0 % 4.3 % Finance leases 4.3 % 4.3 %
Maturity of Operating Lease Liabilities	As of October 31, 2020, remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 3,192 $ 269 Fiscal 2022 11,535 359 Fiscal 2023 9,968 — Fiscal 2024 8,897 — Fiscal 2025 6,540 — Thereafter 27,100 — Total lease payments 67,232 628 Less imputed interest (8,838) (7) Total $ 58,394 $ 621
Maturity of Finance Lease Liabilities	As of October 31, 2020, remaining maturities of lease liabilities are as follows (in thousands): Period Operating leases Finance leases Remaining for Fiscal 2021 $ 3,192 $ 269 Fiscal 2022 11,535 359 Fiscal 2023 9,968 — Fiscal 2024 8,897 — Fiscal 2025 6,540 — Thereafter 27,100 — Total lease payments 67,232 628 Less imputed interest (8,838) (7) Total $ 58,394 $ 621

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
Stockholders' Equity (Tables)	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	A summary of stock option activity for the nine months ended October 31, 2020 is as follows: Number of shares Weighted average exercise price Weighted average remaining contractual term (in years) Aggregate intrinsic value Options outstanding at January 31, 2020 13,448,026 $ 40.64 5.4 $ 1,426,502,005 Options granted 1,368,632 177.44 Options exercised (1,407,370) 17.91 Options forfeited/cancelled (195,630) 121.20 Options outstanding at October 31, 2020 13,213,658 $ 55.83 5.2 $ 2,830,945,659 Options vested and exercisable at October 31, 2020 6,756,111 $ 14.19 3.0 $ 1,728,597,328 Options vested and exercisable at October 31, 2020 and expected to vest thereafter 13,213,658 $ 55.83 5.2 $ 2,830,945,659
Summary of Restricted Stock Unit (RSU) Activity	A summary of restricted stock unit (RSU) activity for the nine months ended October 31, 2020 is as follows: Unreleased restricted stock units Weighted average grant date fair value Balance at January 31, 2020 1,818,622 $ 95.23 RSUs granted 428,503 179.95 RSUs vested (780,989) 95.06 RSUs forfeited/cancelled (97,221) 111.42 Balance at October 31, 2020 1,368,915 120.63
Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted	The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Volatility 39 % - 40% 41% 39 % - 41% 41% Expected term (in years) 6.25 6.25 6.25 - 7.25 5.75 - 6.35 Risk-free interest rate 0.33 % - 0.45% 1.39% - 1.64% 0.33 % - 1.43% 1.39 % - 2.52% Dividend yield —% —% —% —%

Net Income per Share (Tables)

Net Income per Share (Tables)	9 Months Ended
Net Income per Share (Tables)	Oct. 31, 2020
Earnings Per Share [Abstract]
Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock	The numerators and denominators of the basic and diluted net income per share computations for our common stock are calculated as follows (in thousands, except per share data): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Class A Class B Class A Class B Class A Class B Class A Class B Basic Numerator Net income, basic $ 87,262 $ 9,697 $ 73,120 $ 9,125 $ 249,155 $ 27,925 $ 206,862 $ 28,074 Denominator Weighted average shares used in computing net income per share, basic 135,892 15,101 131,720 16,437 135,172 15,150 129,845 17,622 Net income per share, basic $ 0.64 $ 0.64 $ 0.56 $ 0.56 $ 1.84 $ 1.84 $ 1.59 $ 1.59 Diluted Numerator Net income, basic $ 87,262 $ 9,697 $ 73,120 $ 9,125 $ 249,155 $ 27,925 $ 206,862 $ 28,074 Reallocation as a result of conversion of Class B to Class A common stock: Net income, basic 9,697 — 9,125 — 27,925 — 28,074 — Reallocation of net income to Class B common stock — 5,784 — 4,879 — 15,825 — 13,942 Net income, diluted $ 96,959 $ 15,481 $ 82,245 $ 14,004 $ 277,080 $ 43,750 $ 234,936 $ 42,016 Denominator Number of shares used for basic net income per share computation 135,892 15,101 131,720 16,437 135,172 15,150 129,845 17,622 Conversion of Class B to Class A common stock 15,101 — 16,437 — 15,150 — 17,622 — Effect of potentially dilutive common shares 10,718 10,718 10,593 10,593 10,195 10,195 10,657 10,657 Weighted average shares used in computing net income per share, diluted 161,711 25,819 158,750 27,030 160,517 25,345 158,124 28,279 Net income per share, diluted $ 0.60 $ 0.60 $ 0.52 $ 0.52 $ 1.73 $ 1.73 $ 1.49 $ 1.49
Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive	Potential common share equivalents excluded where the inclusion would be anti-dilutive are as follows: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive 85,099 1,362,085 997,236 1,037,362

Revenues by Product (Tables)

Revenues by Product (Tables)	9 Months Ended
Revenues by Product (Tables)	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Summary of Total Revenues	Total revenues consist of the following (in thousands): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Subscription services Veeva Commercial Cloud $ 152,466 $ 115,201 $ 439,858 $ 333,591 Veeva Vault 150,472 111,559 416,817 308,596 Total subscription services $ 302,938 $ 226,760 $ 856,675 $ 642,187 Professional services Veeva Commercial Cloud $ 29,115 $ 18,589 $ 83,109 $ 52,381 Veeva Vault 45,466 35,572 128,524 98,005 Total professional services $ 74,581 $ 54,161 $ 211,633 $ 150,386 Total revenues $ 377,519 $ 280,921 $ 1,068,308 $ 792,573

Information about Geographic _2

Information about Geographic Areas (Tables)	9 Months Ended
Information about Geographic Areas (Tables)	Oct. 31, 2020
Segment Reporting [Abstract]
Revenues by Geographic Area	Total revenues by geographic area were as follows for the periods shown below (in thousands): Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Revenues by geography North America $ 218,110 $ 153,005 $ 614,101 $ 430,441 Europe 102,440 79,832 290,257 226,026 Asia Pacific 46,178 39,057 133,039 110,560 Rest of world (1) 10,791 9,027 30,911 25,546 Total revenues $ 377,519 $ 280,921 $ 1,068,308 $ 792,573 (1) Middle East, Africa, and Latin America
Long-Lived Assets by Geographic Area	Long-lived assets by geographic area are as follows as of the periods shown below (in thousands): October 31, January 31, Long-lived assets by geography North America $ 44,825 $ 51,334 Europe and rest of world 5,701 2,077 Asia Pacific 3,826 1,341 Total long-lived assets $ 54,352 $ 54,752

Summary of Business and Signi_3

Summary of Business and Significant Accounting Policies - Additional Information (Detail)	Oct. 31, 2020industry
Accounting Policies [Abstract]
Number of regulated industries	3

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ in Millions	Nov. 07, 2019	Nov. 01, 2019
Crossix Solutions
Business Acquisition [Line Items]
Percentage of voting interests acquired		100.00%
Consideration transferred		$ 428
Equity retention awards		$ 120
Physicians World
Business Acquisition [Line Items]
Consideration transferred	$ 41
Equity retention awards	$ 15

Acquisitions - Schedule of Pro

Acquisitions - Schedule of Pro Forma Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2019
Business Combinations [Abstract]
Pro forma revenues	$ 298,375	$ 841,989
Pro forma net income	$ 65,998	$ 207,238
Pro forma net income per share:
Basic (in dollars per share)	$ 0.45	$ 1.41
Diluted (in dollars per share)	$ 0.42	$ 1.31

Short-Term Investments - Schedu

Short-Term Investments - Schedule of Short-Term Investments (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 952,039	$ 607,454
Gross unrealized gains	4,344	2,565
Gross unrealized losses	(216)	(4)
Estimated fair value	956,167	610,015
Certificates of deposits
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	15,600	3,500
Gross unrealized gains	13	3
Gross unrealized losses	(1)	0
Estimated fair value	15,612	3,503
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	130,733	100,419
Gross unrealized gains	821	396
Gross unrealized losses	(10)	(1)
Estimated fair value	131,544	100,814
Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	58,602	19,965
Gross unrealized gains	35	5
Gross unrealized losses	(1)	(1)
Estimated fair value	58,636	19,969
Corporate notes and bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	414,837	234,664
Gross unrealized gains	2,528	1,552
Gross unrealized losses	(184)	(2)
Estimated fair value	417,181	236,214
Foreign government bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	32,011	3,397
Gross unrealized gains	33	10
Gross unrealized losses	(17)	0
Estimated fair value	32,027	3,407
U.S. agency obligations
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	52,751
Gross unrealized gains	71
Gross unrealized losses	0
Estimated fair value	52,822
U.S. treasury securities
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	247,505	245,509
Gross unrealized gains	843	599
Gross unrealized losses	(3)	0
Estimated fair value	$ 248,345	$ 246,108

Short-Term Investments - Summar

Short-Term Investments - Summary of Estimated Fair Value of Short-Term Investments, Designated as Available-for-Sale and Classified by Contractual Maturity (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Due in one year or less	$ 434,612	$ 247,592
Due in greater than one year	521,555	362,423
Total	$ 956,167	$ 610,015

Short-Term Investments - Sche_2

Short-Term Investments - Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Certificates of deposits
Schedule of Available-for-sale Securities [Line Items]
Fair value	$ 2,999
Gross unrealized losses	(1)
Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Fair value	11,771	$ 2,623
Gross unrealized losses	(10)	(1)
Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Fair value	13,329	5,589
Gross unrealized losses	(1)	(1)
Corporate notes and bonds
Schedule of Available-for-sale Securities [Line Items]
Fair value	154,408	9,105
Gross unrealized losses	(184)	$ (2)
Foreign government bonds
Schedule of Available-for-sale Securities [Line Items]
Fair value	24,293
Gross unrealized losses	(16)
U.S. treasury securities
Schedule of Available-for-sale Securities [Line Items]
Fair value	21,984
Gross unrealized losses	$ (3)

Deferred Costs - Additional Inf

Deferred Costs - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
Deferred Costs - Additional Information (Detail) - USD ($)	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Deferred Costs [Abstract]
Deferred costs	$ 35,472,000		$ 35,472,000		$ 35,585,000
Amortization of deferred costs	5,000,000	$ 5,000,000	15,000,000	$ 15,000,000
Impairment losses recorded in relation to the costs capitalized	$ 0	$ 0	$ 0	$ 0

Property and Equipment, Net - C

Property and Equipment, Net - Components of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 83,781	$ 80,102
Less accumulated depreciation	(29,429)	(25,350)
Total property and equipment, net	54,352	54,752
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,040	3,040
Building
Property, Plant and Equipment [Line Items]
Property and equipment, gross	20,984	20,984
Land improvements and building improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	22,392	22,392
Equipment and computers
Property, Plant and Equipment [Line Items]
Property and equipment, gross	10,348	11,066
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,218	12,849
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	11,856	9,385
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,943	$ 386

Property and Equipment, Net - A

Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation	$ 2	$ 2	$ 7	$ 6

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Goodwill	$ 436,029		$ 436,029		$ 438,529
Amortization expense	$ 5,000	$ 2,000	$ 15,000	$ 5,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Details of Intangible Assets (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2020	Jan. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 171,176	$ 174,670
Accumulated amortization	(52,011)	(40,069)
Total	119,165	134,601
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	26,180	26,380
Accumulated amortization	(7,422)	(4,808)
Total	$ 18,758	$ 21,572
Remaining useful life (in years)	5 years	5 years 9 months 18 days
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 110,643	$ 111,443
Accumulated amortization	(24,983)	(17,575)
Total	$ 85,660	$ 93,868
Remaining useful life (in years)	8 years 3 months 18 days	9 years
Trade name/Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 13,900	$ 13,900
Accumulated amortization	(3,341)	(720)
Total	$ 10,559	$ 13,180
Remaining useful life (in years)	4 years	4 years 8 months 12 days
Other intangibles
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 20,453	$ 22,947
Accumulated amortization	(16,265)	(16,966)
Total	$ 4,188	$ 5,981
Remaining useful life (in years)	5 years 4 months 24 days	5 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Estimated Amortization Expense (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Remaining for Fiscal 2021	$ 4,570
Fiscal 2022	18,163
Fiscal 2023	18,163
Fiscal 2024	18,160
Fiscal 2025	17,417
Thereafter	42,692
Total	$ 119,165	$ 134,601

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Payables and Accruals [Abstract]
Accrued commissions	$ 6,995	$ 8,951
Accrued bonus	4,433	4,329
Accrued vacation	5,308	3,921
Payroll tax payable	9,647	7,353
Accrued other compensation and benefits	2,523	1,065
Total accrued compensation and benefits	28,906	25,619
Accrued fees payable to salesforce.com	6,255	5,787
Taxes payable	3,899	4,914
Accrued third-party professional services subcontractors' fees	1,507	1,338
Other accrued expenses	10,730	9,581
Total accrued expenses and other current liabilities	$ 22,391	$ 21,620

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Assets
Short-term investments	$ 956,167	$ 610,015
Corporate notes and bonds
Assets
Short-term investments	417,181	236,214
Certificates of deposits
Assets
Short-term investments	15,612	3,503
Asset-backed securities
Assets
Short-term investments	131,544	100,814
Commercial paper
Assets
Short-term investments	58,636	19,969
Foreign government bonds
Assets
Short-term investments	32,027	3,407
U.S. agency obligations
Assets
Short-term investments	52,822
U.S. treasury securities
Assets
Short-term investments	248,345	246,108
Fair value, measurements recurring
Assets
Total	1,150,506	638,058
Liabilities
Total	65	42
Fair value, measurements recurring \| Money market funds
Assets
Cash equivalents:	193,054	24,107
Fair value, measurements recurring \| Corporate notes and bonds
Assets
Cash equivalents:	1,200	2,245
Short-term investments	417,181	236,214
Fair value, measurements recurring \| Certificates of deposits
Assets
Short-term investments	15,612	3,503
Fair value, measurements recurring \| Asset-backed securities
Assets
Short-term investments	131,544	100,815
Fair value, measurements recurring \| Commercial paper
Assets
Cash equivalents:		1,616
Short-term investments	58,636	19,969
Fair value, measurements recurring \| Foreign government bonds
Assets
Short-term investments	32,027	3,407
Fair value, measurements recurring \| U.S. agency obligations
Assets
Short-term investments	52,822
Fair value, measurements recurring \| U.S. treasury securities
Assets
Short-term investments	248,345	246,107
Fair value, measurements recurring \| Foreign currency derivative contracts
Assets
Short-term investments	85	75
Fair value, measurements recurring \| Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	65	42
Fair value, measurements recurring \| Level 1
Assets
Total	193,054	24,107
Liabilities
Total	0	0
Fair value, measurements recurring \| Level 1 \| Money market funds
Assets
Cash equivalents:	193,054	24,107
Fair value, measurements recurring \| Level 1 \| Corporate notes and bonds
Assets
Cash equivalents:	0	0
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Certificates of deposits
Assets
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Asset-backed securities
Assets
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Commercial paper
Assets
Cash equivalents:		0
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Foreign government bonds
Assets
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| U.S. agency obligations
Assets
Short-term investments	0
Fair value, measurements recurring \| Level 1 \| U.S. treasury securities
Assets
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Foreign currency derivative contracts
Assets
Short-term investments	0	0
Fair value, measurements recurring \| Level 1 \| Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	0	0
Fair value, measurements recurring \| Level 2
Assets
Total	957,452	613,951
Liabilities
Total	65	42
Fair value, measurements recurring \| Level 2 \| Money market funds
Assets
Cash equivalents:	0	0
Fair value, measurements recurring \| Level 2 \| Corporate notes and bonds
Assets
Cash equivalents:	1,200	2,245
Short-term investments	417,181	236,214
Fair value, measurements recurring \| Level 2 \| Certificates of deposits
Assets
Short-term investments	15,612	3,503
Fair value, measurements recurring \| Level 2 \| Asset-backed securities
Assets
Short-term investments	131,544	100,815
Fair value, measurements recurring \| Level 2 \| Commercial paper
Assets
Cash equivalents:		1,616
Short-term investments	58,636	19,969
Fair value, measurements recurring \| Level 2 \| Foreign government bonds
Assets
Short-term investments	32,027	3,407
Fair value, measurements recurring \| Level 2 \| U.S. agency obligations
Assets
Short-term investments	52,822
Fair value, measurements recurring \| Level 2 \| U.S. treasury securities
Assets
Short-term investments	248,345	246,107
Fair value, measurements recurring \| Level 2 \| Foreign currency derivative contracts
Assets
Short-term investments	85	75
Fair value, measurements recurring \| Level 2 \| Foreign currency derivative contracts
Liabilities
Foreign currency derivative contracts	$ 65	$ 42

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)
Fair Value Disclosures [Abstract]
Realized foreign currency gain (loss)	$ (1)

Fair Value Measurements - Summa

Fair Value Measurements - Summary Fair Value of Outstanding Derivative Instruments (Detail) - Foreign currency derivative contracts - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Derivatives, Fair Value [Line Items]
Notional amount of foreign currency derivative contracts	$ 10,409	$ 7,304
Fair value of foreign currency derivative contracts	$ 10,390	$ 7,271

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Outstanding Balance Sheet Hedges (Detail) - Foreign currency derivative contracts - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative Assets	$ 85	$ 75
Accrued expenses
Derivatives, Fair Value [Line Items]
Derivative Liabilities	$ 65	$ 42

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Income Tax Disclosure [Abstract]
Effective tax rates	7.40%	8.60%	4.00%	5.40%
Excess tax benefits recognized	$ 17,329	$ 8,931	$ 59,067	$ 39,509

Deferred Revenue, Performance_2

Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Revenue From Contracts With Customers [Line Items]
Unbilled accounts receivable	$ 53,235		$ 53,235		$ 32,817
Subscription services
Revenue From Contracts With Customers [Line Items]
Recognition of deferred revenue	232,000	$ 178,000	409,000	$ 311,000
Revenue expected to be recognized from remaining performance obligations	772,000		772,000
Unbilled accounts receivable	30,000		30,000		15,000
Professional services and other
Revenue From Contracts With Customers [Line Items]
Unbilled accounts receivable	$ 23,000		$ 23,000		$ 18,000

Deferred Revenue, Performance_3

Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable - Performance Obligation Duration (Details) - Subscription services - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-11-01	Oct. 31, 2020
Revenue From Contracts With Customers [Line Items]
Revenue, remaining performance obligation, percentage	73.00%
Revenue, remaining performance obligation, recognition period	12 months

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Leases [Line Items]
Operating lease expense	$ 3	$ 2	$ 9	$ 5
Maximum
Leases [Line Items]
Operating leases, options to extend leases term	9 years		9 years
Finance leases, options to extend leases term	9 years		9 years

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 8,149	$ 5,131
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 8,937	$ 11,656

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information Related to Leases (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020	Oct. 31, 2019
Operating Leases
Lease right-of-use assets	$ 52,824	$ 49,132	$ 24,055
Lease liabilities	10,429		6,401
Lease liabilities, noncurrent	47,965		19,261
Total operating lease liabilities	58,394		25,662
Finance Leases
Property and equipment, at cost	1,738		1,738
Accumulated depreciation	(1,738)		(978)
Property and equipment, net	0		760
Lease liabilities	621		1,029
Lease liabilities, noncurrent	0		621
Total finance lease liabilities	$ 621		$ 1,650
Weighted Average Remaining Lease Term
Operating leases	7 years		5 years 2 months 12 days
Finance leases	7 months 6 days		1 year 7 months 6 days
Weighted Average Discount Rate
Operating leases	4.00%		4.30%
Finance leases	4.30%		4.30%
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	veev:OperatingAndFinanceLeaseLiabilityCurrent	veev:OperatingAndFinanceLeaseLiabilityCurrent
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	veev:OperatingAndFinanceLeaseLiabilityNoncurrent	veev:OperatingAndFinanceLeaseLiabilityNoncurrent
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	veev:OperatingAndFinanceLeaseLiabilityCurrent	veev:OperatingAndFinanceLeaseLiabilityCurrent
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	veev:OperatingAndFinanceLeaseLiabilityNoncurrent	veev:OperatingAndFinanceLeaseLiabilityNoncurrent

Leases- Maturities of lease lia

Leases- Maturities of lease liabilities (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Oct. 31, 2019
Operating leases
Remaining for Fiscal 2021	$ 3,192
Fiscal 2022	11,535
Fiscal 2023	9,968
Fiscal 2024	8,897
Fiscal 2025	6,540
Thereafter	27,100
Total lease payments	67,232
Less imputed interest	(8,838)
Total	58,394	$ 25,662
Finance leases
Remaining for Fiscal 2021	269
Fiscal 2022	359
Fiscal 2023	0
Fiscal 2024	0
Fiscal 2025	0
Thereafter	0
Total lease payments	628
Less imputed interest	(7)
Total	$ 621	$ 1,650

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity (Detail)	9 Months Ended	12 Months Ended
	Oct. 31, 2020USD ($)$ / sharesshares	Jan. 31, 2020USD ($)$ / sharesshares
Number of shares
Options outstanding, Beginning balance (in shares) \| shares	13,448,026
Options granted (in shares) \| shares	1,368,632
Options exercised (in shares) \| shares	(1,407,370)
Options forfeited/cancelled (in shares) \| shares	(195,630)
Options outstanding, Ending balance (in shares) \| shares	13,213,658	13,448,026
Options vested and exercisable (in shares) \| shares	6,756,111
Options vested and exercisable and expected to vest thereafter (in shares) \| shares	13,213,658
Weighted average exercise price
Options outstanding, Beginning balance (in usd per share) \| $ / shares	$ 40.64
Options granted (in usd per share) \| $ / shares	177.44
Options exercised (in usd per share) \| $ / shares	17.91
Options forfeited/cancelled (in usd per share) \| $ / shares	121.20
Options outstanding, Ending balance (in usd per share) \| $ / shares	55.83	$ 40.64
Options vested and exercisable (in usd per share) \| $ / shares	14.19
Options vested and exercisable and expected to vest thereafter (in usd per share) \| $ / shares	$ 55.83
Weighted average remaining contractual term (in years), Options outstanding	5 years 2 months 12 days	5 years 4 months 24 days
Weighted average remaining contractual term (in years), Options vested and exercisable	3 years
Weighted average remaining contractual term (in years), Options vested and exercisable and expected to vest thereafter	5 years 2 months 12 days
Aggregate intrinsic value
Options outstanding \| $	$ 2,830,945,659	$ 1,426,502,005
Options vested and exercisable \| $	1,728,597,328
Options vested and exercisable and expected to vest thereafter \| $	$ 2,830,945,659

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2020USD ($)$ / shares	Oct. 31, 2020USD ($)$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to unvested stock options granted	$ 230	$ 230
Intrinsic value of options exercised	$ 81	$ 266
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant date fair value of options granted (in usd per share) \| $ / shares	$ 105.38	$ 70.44
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of unvested stock (in years)		3 years 4 months 24 days
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of unvested stock (in years)		2 years 4 months 24 days
Unrecognized compensation cost related to unvested RSUs	$ 137	$ 137
Total intrinsic value, vested	$ 68	$ 167

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Restricted Stock Unit (RSU) Activity (Detail) - Restricted Stock Units (RSUs)	9 Months Ended
	Oct. 31, 2020$ / sharesshares
Unreleased restricted stock units
Beginning Balance (in shares) \| shares	1,818,622
RSUs granted (in shares) \| shares	428,503
RSUs vested (in shares) \| shares	(780,989)
RSUs forfeited/cancelled (in shares) \| shares	(97,221)
Ending Balance (in shares) \| shares	1,368,915
Weighted average grant date fair value
Beginning Balance (in usd per share) \| $ / shares	$ 95.23
RSUs granted (in usd per share) \| $ / shares	179.95
RSUs vested (in usd per share) \| $ / shares	95.06
RSUs forfeited/cancelled (in usd per share) \| $ / shares	111.42
Ending Balance (in usd per share) \| $ / shares	$ 120.63

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted (Detail) - Stock Options	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility		41.00%		41.00%
Expected term (in years)	6 years 3 months	6 years 3 months
Risk-free interest rate, Minimum	0.33%	1.39%	0.33%	1.39%
Risk-free interest rate, Maximum	0.45%	1.64%	1.43%	2.52%
Dividend yield	0.00%	0.00%	0.00%	0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	39.00%		39.00%
Expected term (in years)			6 years 3 months	5 years 9 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	40.00%		41.00%
Expected term (in years)			7 years 3 months	6 years 4 months 6 days

Net Income per Share - Numerato

Net Income per Share - Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Weighted average shares used in computing net income per share, basic (in shares)	150,993	148,157	150,322	147,467
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.64	$ 0.56	$ 1.84	$ 1.59
Reallocation as a result of conversion of Class B to Class A common stock:
Weighted average shares used in computing net income per share, diluted (in shares)	161,711	158,750	160,517	158,124
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.60	$ 0.52	$ 1.73	$ 1.49
Class A common stock
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income, basic	$ 87,262	$ 73,120	$ 249,155	$ 206,862
Weighted average shares used in computing net income per share, basic (in shares)	135,892	131,720	135,172	129,845
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.64	$ 0.56	$ 1.84	$ 1.59
Net income, basic	$ 87,262	$ 73,120	$ 249,155	$ 206,862
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic	9,697	9,125	27,925	28,074
Reallocation of net income to Class B common stock	0	0	0	0
Net income, diluted	$ 96,959	$ 82,245	$ 277,080	$ 234,936
Conversion of Class B to Class A common stock (in shares)	15,101	16,437	15,150	17,622
Effect of potentially dilutive common shares (in shares)	10,718	10,593	10,195	10,657
Weighted average shares used in computing net income per share, diluted (in shares)	161,711	158,750	160,517	158,124
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.60	$ 0.52	$ 1.73	$ 1.49
Class B common stock
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income, basic	$ 9,697	$ 9,125	$ 27,925	$ 28,074
Weighted average shares used in computing net income per share, basic (in shares)	15,101	16,437	15,150	17,622
Net income per share attributable to common stockholders, basic (in usd per share)	$ 0.64	$ 0.56	$ 1.84	$ 1.59
Net income, basic	$ 9,697	$ 9,125	$ 27,925	$ 28,074
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic	0	0	0	0
Reallocation of net income to Class B common stock	5,784	4,879	15,825	13,942
Net income, diluted	$ 15,481	$ 14,004	$ 43,750	$ 42,016
Conversion of Class B to Class A common stock (in shares)	0	0	0	0
Effect of potentially dilutive common shares (in shares)	10,718	10,593	10,195	10,657
Weighted average shares used in computing net income per share, diluted (in shares)	25,819	27,030	25,345	28,279
Net income per share attributable to common stockholders, diluted (in usd per share)	$ 0.60	$ 0.52	$ 1.73	$ 1.49

Net Income per Share - Potentia

Net Income per Share - Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive (Detail) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Earnings Per Share [Abstract]
Options and awards to purchase shares not included in the computation of diluted net income per share because their inclusion would be anti-dilutive (in shares)	85,099	1,362,085	997,236	1,037,362

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	Mar. 13, 2017USD ($)	Jan. 26, 2017employee	Oct. 31, 2020USD ($)
Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Minimum order commitment			$ 500,000,000
Amount of first minimum order commitment met			250,000,000
Minimum fee commitment obligation			78,000,000
IQVIA Litigation Matter \| Minimum
Long-term Purchase Commitment [Line Items]
Monetary damages	$ 200,000,000
Medidata Litigation Matter
Long-term Purchase Commitment [Line Items]
Number of former employees \| employee		5
Present to September 1st, 2025 \| Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Minimum order commitment			500,000,000
March 1st 2014 to September 1st, 2020 \| Value-Added Reseller Agreement
Long-term Purchase Commitment [Line Items]
Amount of first minimum order commitment met			$ 250,000,000

Revenues by Product - Summary o

Revenues by Product - Summary of Total Revenues (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020USD ($)industry	Oct. 31, 2019USD ($)	Oct. 31, 2020USD ($)industry	Oct. 31, 2019USD ($)
Disaggregation of Revenue [Line Items]
Number of product areas \| industry	2		2
Total revenues	$ 377,519	$ 280,921	$ 1,068,308	$ 792,573
Veeva Commercial Cloud
Disaggregation of Revenue [Line Items]
Total revenues	152,466	115,201	439,858	333,591
Veeva Vault
Disaggregation of Revenue [Line Items]
Total revenues	150,472	111,559	416,817	308,596
Total subscription services
Disaggregation of Revenue [Line Items]
Total revenues	302,938	226,760	856,675	642,187
Veeva Commercial Cloud
Disaggregation of Revenue [Line Items]
Total revenues	29,115	18,589	83,109	52,381
Veeva Vault
Disaggregation of Revenue [Line Items]
Total revenues	45,466	35,572	128,524	98,005
Total professional services
Disaggregation of Revenue [Line Items]
Total revenues	$ 74,581	$ 54,161	$ 211,633	$ 150,386

Information about Geographic _3

Information about Geographic Areas - Revenues by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Revenues by geography
Total revenues	$ 377,519	$ 280,921	$ 1,068,308	$ 792,573
North America
Revenues by geography
Total revenues	218,110	153,005	614,101	430,441
Europe
Revenues by geography
Total revenues	102,440	79,832	290,257	226,026
Asia Pacific
Revenues by geography
Total revenues	46,178	39,057	133,039	110,560
Rest of world
Revenues by geography
Total revenues	$ 10,791	$ 9,027	$ 30,911	$ 25,546

Information about Geographic _4

Information about Geographic Areas - Long-Lived Assets by Geographic Area (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Long-lived assets by geography
Total long-lived assets	$ 54,352	$ 54,752
North America
Long-lived assets by geography
Total long-lived assets	44,825	51,334
Europe and rest of world
Long-lived assets by geography
Total long-lived assets	5,701	2,077
Asia Pacific
Long-lived assets by geography
Total long-lived assets	$ 3,826	$ 1,341

Uncategorized Items - veev-2020

Label	Element	Value
Accounting Standards Update [Extensible List]	us-gaap_AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 1,208,000
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 1,207,000